| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6174209 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2013 | 5 Pages | 
Abstract
												Our results suggest that chemotherapy administered to treat GTN does indeed affect the ovarian reserve, especially in patients who receive a medication regimen that includes etoposide. Measuring their serum AMH levels might therefore be helpful for counseling GTN patients regarding their ovarian reserve.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												Akira Iwase, Atsuko Sugita, Wakana Hirokawa, Maki Goto, Eiko Yamamoto, Sachiko Takikawa, Tatsuo Nakahara, Tomoko Nakamura, Mika Kondo, Fumitaka Kikkawa, 
											